Immediate Impact
1 from Science/Nature 62 standout
Citing Papers
Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
2024 Standout
Single-cell and spatial transcriptomics analysis of non-small cell lung cancer
2024 Standout
Works of Sumie Koike being referenced
Two Novel ALK Mutations Mediate Acquired Resistance to the Next-Generation ALK Inhibitor Alectinib
2014
Cabozantinib Overcomes Crizotinib Resistance in ROS1 Fusion–Positive Cancer
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Sumie Koike | 504 | 659 | 496 | 19 | 986 | |
| David Taber | 439 | 635 | 463 | 28 | 1.1k | |
| William Dahut | 458 | 318 | 282 | 19 | 875 | |
| C McAleer | 224 | 527 | 461 | 23 | 876 | |
| Axel R. Hanauske | 421 | 418 | 480 | 19 | 1.0k | |
| J. Slingerland | 513 | 583 | 163 | 17 | 912 | |
| H. J. Illiger | 381 | 549 | 262 | 28 | 962 | |
| Bogusława Karaszewska | 304 | 657 | 415 | 28 | 926 | |
| L Pyle | 435 | 293 | 351 | 18 | 796 | |
| Thorunn Helgason | 464 | 420 | 213 | 31 | 1.1k | |
| Fraser Symmans | 594 | 591 | 315 | 21 | 1.1k |
All Works
Loading papers...